Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Contrast medium enhanced MR angiography]

T J Vogl1, Y Hoffmann, A Mühler

  • 1Strahlenklinik und Poliklinik, Universitätsklinikum Rudolph Virchow, Freien Universität Berlin, Standort Wedding.

Der Radiologe
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Quantitative parametric analysis of contrast-enhanced lesions in dynamic MR mammography].

Der Radiologe·2007
Same author

Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography.

European radiology·2006
Same author

Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging.

Academic radiology·2000
Same author

Does a higher concentration of gadolinium chelates improve first-pass cardiac signal changes?

Journal of magnetic resonance imaging : JMRI·1999
Same author

Contrast-enhanced MR imaging of two superparamagnetic RES-contrast agents: functional assessment of experimental radiation-induced liver injury.

Journal of magnetic resonance imaging : JMRI·1999
Same author

Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents.

Journal of magnetic resonance imaging : JMRI·1999
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2024
Same journal

Der Radiologe·2022
Same journal

Der Radiologe·2022
See all related articles

Contrast-enhanced Magnetic Resonance Angiography (CE-MRA) improves imaging by reducing artifacts. Blood-pool contrast agents offer superior visualization for specific extracerebral vascular conditions.

Area of Science:

  • Radiology and Medical Imaging
  • Cardiovascular Imaging
  • Neuroimaging

Background:

  • Standard Magnetic Resonance Angiography (MRA) techniques, such as time-of-flight MRA, are susceptible to artifacts like saturation from turbulent blood flow.
  • Contrast media, including extracellular and blood-pool agents, can mitigate these artifacts in MRA.
  • Contrast-enhanced MRA (CE-MRA) using Gd-DTPA is valuable for cerebral pathologies but limited for extracerebral diseases due to simultaneous visualization of arterial and venous systems.

Purpose of the Study:

  • To evaluate the utility of contrast media in Magnetic Resonance Angiography (MRA).
  • To explore the clinical applications of CE-MRA, particularly for extracerebral pathologies.
  • To assess the effectiveness of blood-pool contrast agents for enhanced vascular imaging.

Main Methods:

Related Experiment Videos

  • Review of standard MRA protocols, including time-of-flight MRA.
  • Application of contrast media (extracellular agents, blood-pool agents like Gd-DTPA) to reduce MRA artifacts.
  • Clinical assessment of CE-MRA for cerebral and extracerebral diseases, focusing on indications like venous sinus thrombosis and AV malformations.

Main Results:

  • Contrast media effectively diminish artifacts encountered in standard MRA techniques.
  • Gd-DTPA-enhanced MRA is clinically valuable for cerebral pathologies.
  • Blood-pool contrast agents (e.g., Gd-DTPA-polylysin, Gd-DTPA-albumin) demonstrate superior contrast and prolonged intravascular persistence, proving effective for extracerebral indications.

Conclusions:

  • CE-MRA, especially with advanced blood-pool contrast agents, enhances diagnostic capabilities for specific vascular conditions.
  • Blood-pool agents offer improved intravascular persistence and excretion profiles, making them ideal for visualizing extracerebral pathologies like occult venous sinus thrombosis and AV malformations.
  • CE-MRA represents a significant advancement in vascular imaging, overcoming limitations of traditional MRA protocols.